| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |